These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6756062)

  • 1. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
    Meltzer HY; So R; Fang VS
    Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 3. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 4. Substituted benzamide drugs as selective neuroleptic agents.
    Jenner P; Marsden CD
    Neuropharmacology; 1981 Dec; 20(12B):1285-93. PubMed ID: 6119638
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pituitary dopamine receptor.
    Labrie F; Di Paolo T; Raymond V; Ferland L; Beaulieu M
    Adv Biochem Psychopharmacol; 1980; 23():217-27. PubMed ID: 6104906
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of ergot compounds with dopamine receptors and endocrine functions.
    Flückiger E
    J Neural Transm Suppl; 1983; 18():189-204. PubMed ID: 6576114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of prolactin secretion: a mini-review.
    Slaunwhite WR
    Prog Clin Biol Res; 1981; 75B():19-29. PubMed ID: 6275411
    [No Abstract]   [Full Text] [Related]  

  • 10. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-relationships between the secretory dynamics of thyrotrophin-releasing hormone, thyrotrophin and prolactin in periovulatory mares: effect of hypothyroidism.
    Alexander SL; Irvine CH; Evans MJ
    J Neuroendocrinol; 2004 Nov; 16(11):906-15. PubMed ID: 15584931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT and DA receptor affinity of arylpiperazine derivatives with terminal benzamide fragment.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Lograno MD; Daniele E; Govoni S
    Farmaco; 1994 Sep; 49(9):567-72. PubMed ID: 7811352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereospecificity of hypothalamo-hypophysial dopamine receptors involved in the control of prolactin secretion in normal man: effects of sulpiride stereoisomers].
    Benfenati F; De Camillis E; Cortelli P; Orlandi F
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1226-32. PubMed ID: 7459063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dopaminergic regulation of hormone secretion of the pituitary gland and the adrenal gland].
    Jungmann E; Böttger B; Magnet W; Schulz F; Schwedes U; Althoff PH; Schöffling K
    Med Welt; 1983 Feb; 34(7):216-9. PubMed ID: 6835089
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides.
    Kohli JD; Glock D; Goldberg LI
    Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of substituted benzamides on prolactin secretion in the rat.
    Kakigi T; Maeda K; Tanimoto K; Kaneda H; Shintani T
    Biol Psychiatry; 1992 Apr; 31(8):827-31. PubMed ID: 1353691
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of prolactin secretion by centrally acting drugs.
    Besser GM; Yeo T; Delitala G; Grossman AB
    Adv Biochem Psychopharmacol; 1980; 24():399-406. PubMed ID: 6105790
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.